-
Mashup Score: 1Genetic testing in prostate cancer management: Considerations informing primary care - 3 year(s) ago
Inherited genetic mutations can significantly increase the risk for prostate cancer (PC), may be associated with aggressive disease and poorer outcomes, and can have hereditary cancer implications fo…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Machine learning generates algorithms that surpasses human-designed algorithms but is inferior to expert assessment integrating clinical and cytologic assessment. Cytokeratin 7/20 may be superseded b…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Hot off the press đ„đ The role of cytokeratin 7/20 coordination revisitedâMachine learning identifies improved interpretative algorithms for cell block immunohistochemistry in aspirates of metastatic carcinoma https://t.co/VK3xpxMGhn #CytoPath #IHCPath #FNAPath https://t.co/DlhCihPXbA
-
-
Mashup Score: 0Does the Y chromosome play a role for outcome in childhood acute lymphoblastic leukemia? - 3 year(s) ago
The cumulative incidence of relapses in acute lymphoblastic leukemia continues to be slightly higher in boys than in girls, with many studies showing an excess of central nervous system relapses. Stu…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Does the Y-Chromosome play a role for outcome in childhood acute lymphoblastic leukemia? New editorial by Valentino Conter et al https://t.co/RLh6wMcrPr
-
-
Mashup Score: 2
Compared to prior data, lung cancer screening rates increased in 2019, and the 2021 expanded criteria will result in a greater number of eligible individuals. Risk-based screening that uses additiona…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#LungCancer screening rates âŹïž in 2019 & the 2021 expanded criteria will result in a greater number of eligible individuals. Risk-based screening that utilizes add'l risk factors may be more inclusive in racial subgroups. https://t.co/GnovTKUVlj @RandiMWilliams2 https://t.co/QKN0YqqnQk
-
-
Mashup Score: 2
Short-term endocrine therapy for 2 to 3Â years might be an alternative for patients who have estrogen receptor-low positive breast cancer instead of the standard 5Â years. More extensive studies and tr…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Available #OpenAcess | Short-term #EndocrineTherapy for 2-3 years might be an alternative for patients who have ER-low positive #BreastCancer instead of the standard 5 years of treatment. https://t.co/Mej4P2KG1M #BCSM https://t.co/8EifwXpa44
-
-
Mashup Score: 0Abbreviated endocrine therapy duration for low estrogen receptorâpositive breast cancer: The counter to extended endocrine therapy - 3 year(s) ago
Five years of adjuvant endocrine therapy is currently the standard approach for patients with breast cancers expressing hormone receptors, even for low-expressing (1%-10%) disease. The article in thi…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This new editorial by @KariWisinski_MD & Johanna E. Poterala MD comments on the article by Cai et al, which indicates that a shorter course of endocrine therapy may be reasonable for low ER-expressing breast cancers. https://t.co/r6bP7jP8mK
-
-
Mashup Score: 0Sexâbased disparities in outcome in pediatric acute lymphoblastic leukemia: a Childrenâs Oncology Group report - 3 year(s) ago
Boys with childhood acute lymphoblastic leukemia have historically experienced inferior outcomes compared to girls; whether these sex-based disparities persist in the context of modern therapy is unk…
Source: American Cancer Society JournalsCategories: Hematologists1, Latest HeadlinesTweet-
B-ALL outcomes are inferior in boys due to increased CNS relapses https://t.co/zM1QONfIhA
-
-
Mashup Score: 10
The authors introduce a functional communication framework that can be used for global pediatric cancer research.
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Just published! Global communication in cancer must adapt to each unique culture. A functional model of communication might advance communication research and practice around the world: https://t.co/1rtfGGE4yI @sisk_md @DylanGraetzMD https://t.co/Jfq66a3C9Q
-
-
Mashup Score: 0
The expression of ABCB1/P-glycoprotein (Pgp) at diagnosis has been used to stratify patients with high-grade osteosarcoma. Adjuvant mifamurtide, combined with high-dose ifosfamide for a poor response…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Mifamurtide added to ifosfamide may be a valid option for high risk osteosarcoma patients. Learn more: https://t.co/zinZ3g00Ob @IRCCS_Rizzoli @IstTumori @unito https://t.co/F4kyUGFcC1
-
-
Mashup Score: 2
The authors introduce a functional communication framework that can be used for global pediatric cancer research.
Source: American Cancer Society JournalsCategories: Hem/Oncs, Latest HeadlinesTweet-
đ«A proposed global framework for pediatric cancer communication research @JournalCancer @OncoAlert https://t.co/CjTXnzuKj1 https://t.co/82bwUObCJK
-
New Review | Genetic testing in #ProstateCancer management: Considerations informing primary care https://t.co/IbJkPxTrH5 @JeffersonUniv @UMichUrology @DanaFarber https://t.co/M3e7gTobdh